1. Home
  2. FC vs VYGR Comparison

FC vs VYGR Comparison

Compare FC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

N/A

Current Price

$19.02

Market Cap

231.6M

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.46

Market Cap

203.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FC
VYGR
Founded
1983
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.6M
203.6M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
FC
VYGR
Price
$19.02
$3.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$26.00
$16.50
AVG Volume (30 Days)
56.3K
407.4K
Earning Date
04-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$267,067,000.00
$10,135,000.00
Revenue This Year
$3.15
$34.04
Revenue Next Year
$4.04
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.16
$2.94
52 Week High
$26.81
$5.55

Technical Indicators

Market Signals
Indicator
FC
VYGR
Relative Strength Index (RSI) 33.50 50.66
Support Level $15.87 $3.33
Resistance Level $21.15 $3.56
Average True Range (ATR) 0.78 0.15
MACD -0.11 0.01
Stochastic Oscillator 21.48 44.16

Price Performance

Historical Comparison
FC
VYGR

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: